title: Improved patient survival in renal transplantation.
abstract: Patient and graft survival in 655 consecutive renal transplants performed at the University of California, San Francisco, was analyzed in two separate groups to assess the results of the low-dose immunosuppressive regimen established in September, 1972. These results show that graft survival is not jeopardized by adopting a policy of low-dose immunosuppressive therapy, but, in fact, that patient survival is improved significantly. This study also shows that cadaver renal transplantation can be performed with a mortality rate comparable to or better than that in patients on chronic hemodialysis.
mesh_terms: D002102:Cadaver; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000031:analogs & derivatives; D011241:Prednisone / Q000627:therapeutic use; D006435:Renal Dialysis; D014184:Transplantation, Homologous / Q000401:mortality
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone